Business Overview

Investing in Medicinal Organic Cannabis Australia (MOCA) is an opportunity to enter the rapidly growing industry of medicinal cannabis in Australia. The country's Narcotics Drugs Amendment Act 2016 has made it legal for patients and doctors to access safe, reliable and legal sources of cannabis for medicinal use. As a result, businesses like MOCA can apply for licenses to cultivate cannabis for medicinal purposes, manufacture medicinal cannabis products, or conduct medicinal cannabis related research under the Medicinal Cannabis Scheme.

MOCA is a licensed medicinal cannabis company with operations based in Sydney, Australia. The company holds various licenses from both the state and federal governments, allowing it to import and export wholesale cannabis medication into and out of Australia. MOCA operates its wholesale activities and distribution out of one of the largest licensed pharmaceutical complexes in Australasia, ensuring high-quality products and efficient distribution.

In 2022, MOCA launched MOCA Health, a natural health clinic focused on medical cannabis via telehealth. This innovative venture has grown significantly since its launch, with a loyal group of patients seeking high-quality organic medication. MOCA Health provides a convenient and accessible way for patients to access medical cannabis products and services through telehealth consultations. The clinic's focus on providing high-quality organic medication ensures that patients receive the best possible treatment and care.

Investing in MOCA provides an opportunity to be part of a company that is at the forefront of the medicinal cannabis industry in Australia. The company's commitment to providing high-quality organic medication, expanding its operations internationally, and developing innovative ventures like MOCA Health make it an attractive option for investors looking to enter this exciting and growing industry.

Medicinal Organic Cannabis Australia (MOCA) has a clear business strategy to become a leading national and international producer, wholesaler and retailer of cannabis-based products. The Company is focused on rapidly expanding to meet the expected demand in the Australian medicinal cannabis market, as well as expanding internationally to cater to the global demand for medical cannabis products.

To achieve this, MOCA is building a range of wholesale MOCA branded cannabis-based products in Australia. The Company is working with the 'best in field' for logistics and distribution of its medical cannabis products, ensuring efficient and reliable delivery to customers. MOCA is also working closely with wholesale clients, including hospitals, medical practitioners and cannabis clinics in Australia, to expand its customer base.

In addition, MOCA is expanding its healthcare client base in Australia and internationally through digital promotions and practitioner partnerships. The Company is leveraging its cultivation and production process to constantly improve its quality and pricing, while supporting its online and offline distribution network.

MOCA's growth strategy is underpinned by its innovative MOCA Health cannabis clinic, which provides the Company with direct access to consumers of its organic medical products. Over the next one to three years, MOCA will continue to grow the business through the manufacture of organic products and development of the MOCA brand. The Company is focused on engaging new patients and working with its patient base to deliver outstanding patient services.

To achieve its growth targets, MOCA will operate on a staged approach, leveraging its licences to bring a variety of federally approved medical cannabis products into its secure pharmaceutical facility in New South Wales. The Company's import licence enables it to wholesale its cannabis products to pharmacies, hospitals and licensed medical professionals, while its export licence enables the Company to sell products to licensed buyers around the world.

As part of its expansion strategy, MOCA is also focused on expanding its cultivation base in Europe exponentially to cater to international demand. The Company's commitment to expanding its operations internationally, while maintaining its focus on providing high-quality organic medication, makes it an attractive option for investors looking to enter the growing industry of medicinal cannabis.

As a vertically integrated cannabis company, MOCA generates revenue from various sources in the medical cannabis industry. The main source of revenue in the first instance is the wholesale of cannabis medications to the healthcare industry in Australia and internationally. The Company is specifically targeting medical cannabis clinics and licensed doctors, providing educational materials and brochures to assist them in prescribing MOCA cannabis products. MOCA is also targeting emerging nations with approved medical marijuana for the wholesale supply of products.

Another source of revenue is the cultivation of raw and refined cannabis. MOCA operates a research and cultivation facility in Italy, enabling the Company to expand its cultivation base in Europe exponentially and cater to international demand for organic medical cannabis products.

In addition to wholesale and cultivation revenue, MOCA Health is focused on delivering organic medicine directly to patients via the MOCA Health clinic. MOCA Health is a natural health clinic focused on medical cannabis, offering telehealth consultations and prescription services. The clinic has grown month on month since its launch and now has a loyal group of patients seeking high-quality organic medication. MOCA Health provides the Company with direct access to consumers of its organic medical products and is a crucial component of the Company's growth strategy.

Overall, MOCA's business model is designed to leverage its licenses to bring a variety of federally approved medical cannabis products into its secure pharmaceutical facility in New South Wales, including CBD and THC capsules, CBD oils and tinctures, sublinguals, and concentrates. The Company's import license enables it to wholesale its cannabis products to pharmacies, hospitals, and licensed medical professionals, while its export license enables the Company to sell products to licensed buyers around the world.

Our value proposition is to provide patients with safe, reliable and legal access to high quality, sustainable, and organic cannabis medication. Our focus on cultivation, research, and development of cannabis-based products enables us to provide patients with a wide range of products that can effectively treat a variety of medical conditions.

At MOCA, we understand the importance of providing access to safe and effective medical solutions to patients. As a result, we have developed a range of educational materials and brochures for medical professionals to assist in prescribing our cannabis products to their patients.

We believe that patients seeking innovative medical solutions to restore health and alleviate sickness should have access to the highest quality products available. Our commitment to sustainable and organic cultivation methods ensures that our products are environmentally friendly and free of harmful pesticides or chemicals.

As a leading national and international producer, wholesaler, and retailer of cannabis-based products, we are committed to meeting the growing demand for safe and effective medical solutions. Our focus on expanding our health care client base in Australia and internationally through digital promotions and practitioner partnerships ensures that patients have access to our high-quality products wherever they are located.

We are proud to be at the forefront of the emerging medical cannabis industry, and we are committed to making a positive impact on the lives of patients around the world.